Literature DB >> 21821918

Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma.

Gulab S Zode1, Markus H Kuehn, Darryl Y Nishimura, Charles C Searby, Kabhilan Mohan, Sinisa D Grozdanic, Kevin Bugge, Michael G Anderson, Abbot F Clark, Edwin M Stone, Val C Sheffield.   

Abstract

Mutations in myocilin (MYOC) are the most common genetic cause of primary open angle glaucoma (POAG), but the mechanisms underlying MYOC-associated glaucoma are not fully understood. Here, we report the development of a transgenic mouse model of POAG caused by the Y437H MYOC mutation; the mice are referred to herein as Tg-MYOC(Y437H) mice. Analysis of adult Tg-MYOC(Y437H) mice, which we showed express human MYOC containing the Y437H mutation within relevant eye tissues, revealed that they display glaucoma phenotypes (i.e., elevated intraocular pressure [IOP], retinal ganglion cell death, and axonal degeneration) closely resembling those seen in patients with POAG caused by the Y437H MYOC mutation. Mutant myocilin was not secreted into the aqueous humor but accumulated in the ER of the trabecular meshwork (TM), thereby inducing ER stress in the TM of Tg-MYOC(Y437H) mice. Furthermore, chronic and persistent ER stress was found to be associated with TM cell death and elevation of IOP in Tg-MYOC(Y437H) mice. Reduction of ER stress with a chemical chaperone, phenylbutyric acid (PBA), prevented glaucoma phenotypes in Tg-MYOC(Y437H) mice by promoting the secretion of mutant myocilin in the aqueous humor and by decreasing intracellular accumulation of myocilin in the ER, thus preventing TM cell death. These results demonstrate that ER stress is linked to the pathogenesis of POAG and may be a target for treatment in human patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821918      PMCID: PMC3163970          DOI: 10.1172/JCI58183

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

Review 1.  Number of people with glaucoma worldwide.

Authors:  H A Quigley
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

Review 2.  ER stress and diseases.

Authors:  Hiderou Yoshida
Journal:  FEBS J       Date:  2007-02       Impact factor: 5.542

3.  The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice.

Authors:  Rebecca M Sappington; Brian J Carlson; Samuel D Crish; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

4.  Ultrastructural localization of myocilin in human trabecular meshwork cells and tissues.

Authors:  J Ueda; K K Wentz-Hunter; E L Cheng; T Fukuchi; H Abe; B Y Yue
Journal:  J Histochem Cytochem       Date:  2000-10       Impact factor: 2.479

5.  Fluctuations of intraocular pressure during the day in open-angle glaucoma, normal-tension glaucoma and normal subjects.

Authors:  S C Saccà; M Rolando; A Marletta; A Macrí; P Cerqueti; G Ciurlo
Journal:  Ophthalmologica       Date:  1998       Impact factor: 3.250

6.  Programmed cell death of retinal ganglion cells during experimental glaucoma.

Authors:  E Garcia-Valenzuela; S Shareef; J Walsh; S C Sharma
Journal:  Exp Eye Res       Date:  1995-07       Impact factor: 3.467

7.  Quantitative trait loci associated with murine central corneal thickness.

Authors:  Geoffrey D Lively; Demelza Koehn; Adam Hedberg-Buenz; Kai Wang; Michael G Anderson
Journal:  Physiol Genomics       Date:  2010-04-27       Impact factor: 3.107

8.  Rescue of glaucoma-causing mutant myocilin thermal stability by chemical chaperones.

Authors:  J Nicole Burns; Susan D Orwig; Julia L Harris; J Derrick Watkins; Douglas Vollrath; Raquel L Lieberman
Journal:  ACS Chem Biol       Date:  2010-05-21       Impact factor: 5.100

9.  A rat model of chronic pressure-induced optic nerve damage.

Authors:  J C Morrison; C G Moore; L M Deppmeier; B G Gold; C K Meshul; E C Johnson
Journal:  Exp Eye Res       Date:  1997-01       Impact factor: 3.467

10.  Identification of a gene that causes primary open angle glaucoma.

Authors:  E M Stone; J H Fingert; W L Alward; T D Nguyen; J R Polansky; S L Sunden; D Nishimura; A F Clark; A Nystuen; B E Nichols; D A Mackey; R Ritch; J W Kalenak; E R Craven; V C Sheffield
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

View more
  147 in total

1.  Differential Misfolding Properties of Glaucoma-Associated Olfactomedin Domains from Humans and Mice.

Authors:  Athéna C Patterson-Orazem; Shannon E Hill; Yiming Wang; Iramofu M Dominic; Carol K Hall; Raquel L Lieberman
Journal:  Biochemistry       Date:  2019-03-12       Impact factor: 3.162

Review 2.  A molecular mechanism for glaucoma: endoplasmic reticulum stress and the unfolded protein response.

Authors:  Robert R H Anholt; Mary Anna Carbone
Journal:  Trends Mol Med       Date:  2013-07-19       Impact factor: 11.951

3.  Clinical and genetic characterization of a large primary open angle glaucoma pedigree.

Authors:  Mohideen Abdul Kader; Prasanthi Namburi; Sarika Ramugade; R Ramakrishnan; Subbiah R Krishnadas; Ben R Roos; Sundaresan Periasamy; Alan L Robin; John H Fingert
Journal:  Ophthalmic Genet       Date:  2016-06-29       Impact factor: 1.803

4.  Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma.

Authors:  Dustin J E Huard; Vincent M Crowley; Yuhong Du; Ricardo A Cordova; Zheying Sun; Moya O Tomlin; Chad A Dickey; John Koren; Laura Blair; Haian Fu; Brian S J Blagg; Raquel L Lieberman
Journal:  ACS Chem Biol       Date:  2018-02-20       Impact factor: 5.100

5.  Lymphatic regulator PROX1 determines Schlemm's canal integrity and identity.

Authors:  Dae-Young Park; Junyeop Lee; Intae Park; Dongwon Choi; Sunju Lee; Sukhyun Song; Yoonha Hwang; Ki Yong Hong; Yoshikazu Nakaoka; Taija Makinen; Pilhan Kim; Kari Alitalo; Young-Kwon Hong; Gou Young Koh
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

6.  Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism.

Authors:  Amirthaa Suntharalingam; Jose F Abisambra; John C O'Leary; John Koren; Bo Zhang; Myung Kuk Joe; Laura J Blair; Shannon E Hill; Umesh K Jinwal; Matthew Cockman; Adam S Duerfeldt; Stanislav Tomarev; Brian S J Blagg; Raquel L Lieberman; Chad A Dickey
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

7.  Activation of AMP-activated protein kinase by metformin ablates angiotensin II-induced endoplasmic reticulum stress and hypertension in mice in vivo.

Authors:  Quanlu Duan; Ping Song; Ye Ding; Ming-Hui Zou
Journal:  Br J Pharmacol       Date:  2017-05-31       Impact factor: 8.739

8.  Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy.

Authors:  Norihiko Yokoi; Yuko Fukata; Daisuke Kase; Taisuke Miyazaki; Martine Jaegle; Toshika Ohkawa; Naoki Takahashi; Hiroko Iwanari; Yasuhiro Mochizuki; Takao Hamakubo; Keiji Imoto; Dies Meijer; Masahiko Watanabe; Masaki Fukata
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

Review 9.  Evaluating retinal ganglion cell loss and dysfunction.

Authors:  Ben Mead; Stanislav Tomarev
Journal:  Exp Eye Res       Date:  2016-08-12       Impact factor: 3.467

10.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.